Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for severe nausea and vomiting of pregnancy
NCT05452174Phase 2Withdrawn
- Sponsor
- Northwestern University
- Start
- Jun 2022
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
A Phase 2 trial of mirtazapine in nausea and vomiting of pregnancy (NVP), hyperemesis gravidarum (HG), sponsored by Northwestern University. Planned start Jun 2022; status: withdrawn.
02
Drugs
mirtazapine
03
Conditions
nausea and vomiting of pregnancy (NVP)hyperemesis gravidarum (HG)
Beyond the preview
Go deeper on NCT05452174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05452174.